Food News and Research

RSS

Opinions: G20 development approach; defense of DDT for malaria control; U.S. foreign aid; human trafficking

Leaders have been debating how to 'rebalance' the global economy and reform financial institutions - all challenging subjects. But I also am reminding my colleagues that all these goals, however crucial, are insufficient, Lee Myung-bak, the president of the Republic of Korea, writes in a Washington Post opinion piece.

10 Nov 2010

Cholera outbreak in PNG makes officials wary

Cholera has been confirmed as the cause of death of 16 persons on a remote island in Papua New Guinea which is close to Australia's maritime border. The first case was detected on Daru Island in Western Province three weeks ago. Since then 12 adults and 4 children have died, and 320 others have been treated for the infection.

10 Nov 2010

Obese teens become obese adults

A new report shows that obese adolescent Americans tend to carry their extra weight into adulthood. The nationally representative study of American youth showed that one in 12 teenagers became severely obese as they entered adulthood with some 100 pounds above their ideal weight. And nearly half the girls and more than a third of the boys who are obese as teenagers grew up to be obese adults with a high risk of developing heart disease, diabetes and certain types of cancers.

10 Nov 2010

Appeals court upholds five-year exclusivity period for Shire's VYVANSE

Shire plc, the global specialty biopharmaceutical company, announces that the U.S. Court of Appeals for the District of Columbia Circuit has affirmed the ruling of the U.S. District Court for the District of Columbia and the U.S. Food and Drug Administration to grant five-year New Chemical Entity exclusivity to lisdexamfetamine dimesylate, currently marketed by Shire U.S. Inc. under the name VYVANSE(R).

10 Nov 2010

Bioniche Life Sciences announces first quarter fiscal 2011 results

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for the first quarter of its 2011 fiscal year (ended September 30, 2010).

10 Nov 2010

Positive results from XOMA 052 study in patients with uveitis of Behcet's disease

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced additional positive results from an open-label pilot study of XOMA 052 in patients with uveitis of Behcet's disease who were suffering from vision-threatening exacerbations despite maximal doses of immunosuppressive medicines.

10 Nov 2010

China Medical Technologies' EGFR PCR Assay for lung cancer targeted drugs receives Chinese SFDA approval

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it has received approval for its real-time PCR-based Epidermal Growth Factor Receptor Assay (the "EGFR PCR Assay") for the use of lung cancer targeted drugs from the State Food and Drug Administration of China (the "SFDA").

10 Nov 2010

Experts to discuss public health issues on using mobile health technology at 2010 mHealth Summit

As obesity rates and the cost of healthcare continue to be on the rise, the 2010 mHealth Summit in Washington D.C. is bringing together industry thought leaders, researchers, and policy makers to discuss the opportunities to address pressing public health issues utilizing mobile health technology.

10 Nov 2010

Pres. Obama emphasizes U.S.-Indian partnerships to track, fight diseases

On his final day in India as part of his 10-day Asia-Pacific tour, President Barack Obama on Monday addressed the joint session of the Indian Parliament in New Dehli, where he emphasized the importance of U.S.-Indian partnerships to tackle disease and improve education, Indo-Asian News Service/Hindustan Times reports (11/8).

10 Nov 2010

Popular antimicrobial chemicals may not be safe for human health and environment

Killing microorganisms has become a national obsession. A pair of antimicrobial compounds known as triclosan and triclocarban are lately the weapons of choice in our war of attrition against the microbial world. Both chemicals are found in an array of personal care products like antimicrobial soaps, and triclosan also is formulated into everyday items ranging from plastics and toys to articles of clothing.

10 Nov 2010

BioInvent receives FDA IND clearance for BI-204 Phase II trial in cardiovascular disease

BioInvent International AB today announces IND clearance from the U.S. Food & Drug Administration (FDA) to initiate a Phase II study for BI-204. BI-204 is a human monoclonal antibody that specifically targets oxidized forms of a low-density lipoprotein (LDL) which has been linked to increased inflammatory processes leading to plaque formation in the blood vessel walls. BI-204 is being co-developed with Genentech for secondary prevention of cardiovascular events in patients with acute coronary syndrome (ACS).

10 Nov 2010

Orexo third quarter net revenues decrease to MSEK 35.9

"During the third quarter, Abstral™ sales were 480% higher than in the same period last year. Sales of Edluar™, Orexo's sublingual zolpidem treatment for insomnia, continue to grow more strongly from a low base, with new stock being ordered for the first time since launch and generating royalty income for Orexo.

10 Nov 2010

Sodexo reports 3.9% increase in revenues for fiscal 2010

Sodexo: At the Board of Directors meeting held on November 8, 2010 and chaired by Pierre Bellon, Sodexo CEO Michel Landel presented the Fiscal 2010 performance.

10 Nov 2010

Enrollment complete in Nabi's second NicVAX Phase III clinical trial for nicotine addiction

Nabi Biopharmaceuticals announced today that it has completed enrollment in the second Phase III clinical trial of NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary investigational candidate vaccine being developed to treat nicotine addiction and prevent smoking relapse.

10 Nov 2010

Investigations examine Medicare’s dialysis system, CT scanners and drugs

ProPublica reports on the costs and risks associated with dialysis: "In 1972, after a month of deliberation, Congress launched the nation's most ambitious experiment in universal health care: a change to the Social Security Act that granted comprehensive coverage under Medicare to virtually anyone diagnosed with kidney failure, regardless of age or income.

10 Nov 2010

Doctor ties to drug companies decline, but remain high, survey finds

The Associated Press: "Doctors have sharply cut some financial ties to drug companies, thanks to increased scrutiny about relationships that critics say improperly influence medical treatment," a survey published in the Archives of Internal Medicine found.

10 Nov 2010

Federal inspectors crack down on corrupt drug company executives

"Federal inspectors want to prevent drug-company executives from doing business with the U.S. government when their companies are convicted of Medicare fraud," The Washington Post reports. New guidelines from the Department of Health and Human Services say "executives can be barred from contracting with federal health programs when they knew, or if the inspector general concludes they should have known, about fraud at their firms."

10 Nov 2010

Cholera cases continue to rise in Haitian capital

Officials have recorded more than 70 cholera cases in the Haitian capital Port-au-Prince and fear for a substantial rise in numbers if the epidemic continues. Pan American Health Organization (PAHO) Deputy Director Jon Kim Andrus said, “As of Monday, the Ministry of Health was reporting more than 9,100 hospitalized cases and some 583 deaths in some 240 communities… These include 73 cases reported in Port-au-Prince. We expect these numbers to continue to rise as more cases are detected.”

9 Nov 2010

ArQule reduces third quarter net loss to $6,394,000

ArQule, Inc. today reported its results of operations for the fiscal quarter and nine months ended September 30, 2010.

9 Nov 2010

Amount of healthy foods must be adapted to limit weight gain

Overweight children reported more frequent intake of healthy foods such as fruit, vegetables, fish, brown bread and potatoes as well as low-energy cheese and yoghurt compared with normal weight children.

9 Nov 2010